EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The Effect of β-Lactam Antibiotics on the Evolution of Ceftazidime/Avibactam and Cefiderocol Resistance in KPC-Producing Klebsiella pneumoniae

Ping Zhang, Huangdu Hu, Qiucheng Shi, Long Sun, Xueqing Wu iD, Xiaoting Hua iD, Alan McNally iD, Yan Jiang, Yunsong Yu iD, Xiaoxing Du iD

Antimicrobial Agents and Chemotherapy · 16.02.2023

DOI: 10.1128/aac.01279-22 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Antimicrobial Agents and Chemotherapy, online erschienen am 16.02.2023. Verfasst von Ping Zhang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Diseases, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China. Hauptthemen laut MEDLINE: Ceftazidime, Klebsiella Infections. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical Research Council, NSFC | NSFC-Zhejiang Joint Fund | 浙江省科学技术厅 | Natural Science Foundation of Zhejiang Province, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In this study, we aimed to clarify the evolutionary trajectory of a Klebsiella pneumoniae carbapenemase (KPC)-producing Klebsiella pneumoniae (KPC-Kp) population during β-lactam antibiotic therapy. Five KPC-Kp isolates were collected from a single patient.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CeftazidimeKlebsiella InfectionsHumansKlebsiella pneumoniaeMeropenemKlebsiellaMoxalactamAnti-Bacterial AgentsAzabicyclo Compoundsbeta-LactamasesBacterial ProteinsDrug CombinationsMicrobial Sensitivity TestsCefiderocol

Stichwörter der Autor:innen

amplificationblaKPC-2cefiderocolceftazidime/avibactamevolutionmutationβ-lactam antibiotics

Substanzen

CeftazidimeMeropenemMoxalactamAnti-Bacterial AgentsAzabicyclo Compoundsbeta-LactamasesBacterial ProteinsDrug CombinationsCefiderocolavibactam, ceftazidime drug combination

Autor:innen und Institutionen

  • Department of Infectious Diseases, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China.
  • Key Laboratory of Microbial Technology and Bioinformatics of Zhejiang Province, Hangzhou, China.
  • Regional Medical Center for National Institute of Respiratory Diseases, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China.
  • Department of Clinical Laboratory, Hangzhou Women's Hospital (Hangzhou Maternity and Child Health Care Hospital), Hangzhou, China.
  • Institute of Microbiology and Infection, College of Medical and Dental Sciences, University of Birmingham, Birmingham, United Kingdom.

ORCID-Profile: Xueqing Wu, Xiaoting Hua, Alan McNally, Yunsong Yu, Xiaoxing Du

Förderung

  • Medical Research Council
  • NSFC | NSFC-Zhejiang Joint Fund | 浙江省科学技术厅 | Natural Science Foundation of Zhejiang Province
  • National Natural Science Foundation of China

Zitieren

APA

Zhang, P., Hu, H., Shi, Q., Sun, L., Wu, X., Hua, X., McNally, A., Jiang, Y., Yu, Y., & Du, X. (2023). The Effect of β-Lactam Antibiotics on the Evolution of Ceftazidime/Avibactam and Cefiderocol Resistance in KPC-Producing Klebsiella pneumoniae. Antimicrobial Agents and Chemotherapy. https://doi.org/10.1128/aac.01279-22

Vancouver

Zhang P, Hu H, Shi Q, Sun L, Wu X, Hua X, et al. The Effect of β-Lactam Antibiotics on the Evolution of Ceftazidime/Avibactam and Cefiderocol Resistance in KPC-Producing Klebsiella pneumoniae. Antimicrobial Agents and Chemotherapy. 2023. doi:10.1128/aac.01279-22

BibTeX
@article{Zhang2023,
  author = {Zhang, Ping and Hu, Huangdu and Shi, Qiucheng and Sun, Long and Wu, Xueqing and Hua, Xiaoting and McNally, Alan and Jiang, Yan and Yu, Yunsong and Du, Xiaoxing},
  title = {The Effect of β-Lactam Antibiotics on the Evolution of Ceftazidime/Avibactam and Cefiderocol Resistance in KPC-Producing Klebsiella pneumoniae},
  journal = {Antimicrobial Agents and Chemotherapy},
  year = {2023},
  doi = {10.1128/aac.01279-22}
}
Kostenlos starten →